Page last updated: 2024-10-25

cimetidine and Intertrochanteric Fractures

cimetidine has been researched along with Intertrochanteric Fractures in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lambers, AP1
D'Alessandro, P1
Yates, P1
Grisso, JA1
Kelsey, JL1
O'Brien, LA1
Miles, CG1
Sidney, S1
Maislin, G1
LaPann, K1
Moritz, D1
Peters, B1

Reviews

1 review available for cimetidine and Intertrochanteric Fractures

ArticleYear
Defining Cephalomedullary Nail Breakage Rates: A Systematic Review and Meta-Analysis.
    Journal of orthopaedic trauma, 2023, 10-01, Volume: 37, Issue:10S

    Topics: Cimetidine; Databases, Factual; Femur; Hip Fractures; Humans; Language

2023

Other Studies

1 other study available for cimetidine and Intertrochanteric Fractures

ArticleYear
Risk factors for hip fracture in men. Hip Fracture Study Group.
    American journal of epidemiology, 1997, May-01, Volume: 145, Issue:9

    Topics: Activities of Daily Living; Aged; Body Mass Index; Case-Control Studies; Cimetidine; Exercise; Hip F

1997